Synmosa Biopharma Corporation (TPEX:4114)

Synmosa Biopharma Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 8, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	17,351	14,499	14,706	16,021	7,016	6,814
Market Cap Growth	6.97%	-1.41%	-8.21%	128.36%	2.96%	20.87%
Enterprise Value	18,093	16,554	17,100	19,459	10,892	11,385
Last Close Price	34.60	30.68	30.79	34.75	15.05	14.33
PE Ratio	22.77	21.18	24.72	20.05	23.09	10.68
Forward PE	-	35.88	35.88	35.88	35.88	35.88
PS Ratio	2.89	2.61	2.86	3.65	2.17	2.24
PB Ratio	1.77	1.73	1.82	2.41	1.15	1.14
P/TBV Ratio	2.19	2.16	2.39	3.38	1.67	1.73
P/FCF Ratio	36.11	25.61	48.24	31.98	19.39	68.14
P/OCF Ratio	24.39	18.57	28.73	25.42	15.42	26.79
EV/Sales Ratio	3.02	2.98	3.33	4.44	3.37	3.75
EV/EBITDA Ratio	15.54	15.38	18.43	25.58	22.83	25.99
EV/EBIT Ratio	21.73	22.34	27.72	42.24	58.33	76.15
EV/FCF Ratio	37.66	29.24	56.09	38.84	30.10	113.85
Debt / Equity Ratio	0.27	0.30	0.30	0.51	0.57	0.62
Debt / EBITDA Ratio	2.25	2.37	2.56	4.32	7.15	8.30
Debt / FCF Ratio	5.52	4.50	7.98	6.70	9.57	37.02
Asset Turnover	0.46	0.46	0.45	0.41	0.31	0.32
Inventory Turnover	1.79	1.83	1.99	1.97	1.59	1.74
Quick Ratio	1.85	1.54	1.35	1.10	0.95	0.94
Current Ratio	2.70	2.42	2.14	1.73	1.64	1.91
Return on Equity (ROE)	5.99%	5.68%	5.49%	9.71%	1.93%	8.82%
Return on Assets (ROA)	4.06%	3.85%	3.36%	2.68%	1.13%	0.98%
Return on Capital (ROIC)	4.58%	4.31%	3.75%	2.94%	1.21%	1.06%
Return on Capital Employed (ROCE)	7.30%	7.20%	6.40%	5.20%	2.20%	1.70%
Earnings Yield	4.18%	4.72%	4.04%	4.99%	4.33%	9.37%
FCF Yield	2.77%	3.91%	2.07%	3.13%	5.16%	1.47%
Dividend Yield	1.58%	1.78%	1.61%	1.31%	2.31%	1.28%
Payout Ratio	31.51%	33.41%	32.69%	18.60%	26.32%	7.16%
Buyback Yield / Dilution	-2.99%	-3.52%	-3.84%	0.79%	-2.35%	-9.76%
Total Shareholder Return	-1.41%	-1.74%	-2.22%	2.10%	-0.04%	-8.48%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.